Xelamin

Xelamin (Exemestane) is an oral aromatase inhibitor used in postmenopausal women for hormone receptor-positive breast cancer treatment. This non-steroidal medication works by reducing estrogen levels to slow tumor growth. Suitable for prescription-based therapy.

Xelamin is primarily used to treat hormone receptor-positive breast cancer in postmenopausal women. It may also be prescribed off-label for other estrogen-sensitive conditions. Patients often ask, 'What is Exemestane used for?' to understand its role in cancer therapy.

Xelamin works by lowering estrogen production in the body, which can help slow the growth of certain breast cancers. Users may notice improved symptom management over time, though individual responses vary.

Xelamin should be taken exactly as prescribed by a healthcare provider. Avoid use if pregnant, breastfeeding, or with a history of osteoporosis. Regular monitoring of bone health and cholesterol levels is recommended during treatment.

Xelamin may interact with hormonal therapies, CYP3A4 inhibitors, or estrogen-containing medications. Alcohol and certain supplements could also affect its efficacy. Always disclose all medications to your doctor before starting Xelamin.